Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Medical Genetics

Standard of Care: Treatment and Management of CPT II Deficiency

At a Glance

Managing CPT II deficiency focuses on preventing muscle breakdown by avoiding triggers like prolonged fasting, extreme exercise, and illness. Treatment involves a high-carbohydrate, low long-chain fat diet supplemented with MCT oil or triheptanoin. A metabolic crisis requires immediate IV D10 glucose.

Managing CPT II deficiency is about balancing the body’s energy needs and avoiding the “triggers” that force the body to use fuel it cannot process. By working closely with a metabolic specialist, families can create a “safety net” that allows for a full and active life [1][2].

Avoiding the Triggers

The core of CPT II management is preventing catabolism—a state where the body begins breaking down its own tissues (like muscle) for energy because it lacks enough fuel from food [3]. To prevent this, three main triggers must be managed:

  • Prolonged Fasting: Going too long without eating is a primary trigger. However, “fasting” means different things for different ages. For infants, fasting limits are very short. For adults, sleeping through the night is often safe, provided they eat a complex carbohydrate snack before bed. You must ask your doctor for your specific safe fasting limits (e.g., maximum hours without food during the day and overnight) [4][3].
  • Intense Exercise: Strenuous or prolonged physical activity can overwhelm the muscle’s energy supply. Managing exercise involves “fueling up” with a carbohydrate-electrolyte sports drink (like Gatorade or a prescribed alternative) before and during activities, like hiking or sports games [5][2].
  • Illness and Fever: Infections increase the body’s energy demands significantly. Fever protocols usually include extra carbohydrate-rich drinks and sometimes early medical intervention to prevent a crisis [3][4].

Dietary Management: Fueling the “Engine”

Since the body cannot efficiently use long-chain fats, the diet is adjusted to provide alternative fuel sources:

  • High-Carbohydrate Diet: Carbohydrates are the primary fuel source. For daily meals, this means relying on complex, slow-burning carbohydrates (like whole grains, oats, and starchy vegetables) to maintain stable energy. Simple sugars (like sports drinks or juices) are generally reserved for acute situations, like during exercise or illness [6][1].
  • Low Long-Chain Fat: Restricting heavy fats (like those found in many oils, fried foods, and fatty meats) reduces the “clog” in the metabolic pathway [7].
  • Alternative Fats (MCT and Triheptanoin): Medium-chain triglycerides (MCT oil) and a specialized medical oil called triheptanoin (brand name Dojolvi) provide a type of fat that can bypass the “blocked gate” in CPT II deficiency [8][9]. Triheptanoin can make up a portion (often up to 35%) of total daily calories, as directed by a specialist, and has been shown to reduce hospitalizations [10][11].

Recognizing and Managing a Crisis

A metabolic crisis in CPT II deficiency often presents as rhabdomyolysis—the rapid breakdown of muscle tissue [2].

  • Signs of Crisis: Intense muscle pain (myalgia), severe weakness, and dark-colored (tea or cola-colored) urine [2][12].
  • The Risk: When muscle breaks down, it releases a protein called myoglobin, which can damage the kidneys, leading to acute kidney injury [13][14].
  • Emergency Protocol: If a crisis starts, the standard of care is immediate and aggressive IV hydration with high concentrations of glucose (sugar), specifically D10 (10% dextrose) [6][15]. This stops the muscle breakdown by providing an instant fuel source and flushes the kidneys to prevent damage [15][16]. Standard ER fluids like Normal Saline or D5 are often insufficient.

Proactive Monitoring

Patients and parents must proactively monitor physical symptoms—such as unusual muscle fatigue, cramping, or changes in urine color—especially during illness or after intense activity [12]. If these warning signs appear, you should contact your medical team to have Creatine Kinase (CK) blood tests ordered at a clinic or hospital. CK is a muscle enzyme that leaks into the blood during muscle breakdown [12]. Knowing your “baseline” (normal) CK level helps doctors determine the severity of a new episode and whether hospital-level care is required [12][1].

Common questions in this guide

What triggers a CPT II deficiency metabolic crisis?
The main triggers include prolonged fasting, strenuous exercise, and illnesses or fevers. These situations rapidly increase the body's energy demands, leading to muscle breakdown when long-chain fats cannot be processed properly.
What is the best diet for CPT II deficiency?
Management typically involves a diet high in complex carbohydrates and very low in long-chain fats. Metabolic specialists also frequently prescribe alternative fats, such as MCT oil or triheptanoin (Dojolvi), which provide energy that bypasses the metabolic block.
How long can I fast if I have CPT II deficiency?
Safe fasting limits vary based on age and individual health. Infants have very short fasting limits, while adults may safely sleep through the night by having a complex carbohydrate snack before bed. You must work with your metabolic doctor to establish your specific safe fasting hours.
What should I do during a CPT II metabolic crisis?
During a crisis, immediate emergency medical attention is required. The standard protocol involves aggressive IV hydration with 10% dextrose (D10) glucose to stop muscle breakdown, provide immediate fuel, and flush the kidneys to prevent damage.
Can I exercise with CPT II deficiency?
Yes, you can stay active, but you must 'fuel up' to protect your muscles. This typically involves consuming a carbohydrate-electrolyte sports drink or prescribed alternative before and during prolonged or intense activities.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Can you help us create a written 'Emergency Letter' for the ER that specifies exactly how much D10 IV glucose my child or I should receive during an illness?
  2. 2.What is our specific safe 'fasting limit' during the day, and does this apply to sleeping overnight?
  3. 3.What is the specific target dose of triheptanoin (Dojolvi) for my/my child's weight and daily caloric needs?
  4. 4.How can we adjust our exercise routine to stay active, and what specific sports drinks do you recommend for 'fueling up' during activity?
  5. 5.At what point should we seek medical attention to have CK blood levels tested versus managing symptoms at home?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (16)
  1. 1

    Carnitine palmitoyltransferase-II deficiency: case presentation and review of the literature.

    Mccormick BJ, Chirila RM

    Romanian journal of internal medicine = Revue roumaine de medecine interne 2021; (59(4)):420-424 doi:10.2478/rjim-2021-0021.

    PMID: 34118800
  2. 2

    Myopathic Carnitine Palmitoyltransferase II (CPT II) Deficiency: A Rare Cause of Acute Kidney Injury and Cardiomyopathy.

    Castillo E, Medina D, Schoenmann N

    Cureus 2023; (15(10)):e46595 doi:10.7759/cureus.46595.

    PMID: 37933340
  3. 3

    Battling Recurrent Rhabdomyolysis in Carnitine Palmitoyltransferase II Deficiency.

    Isar MM, Begum HA, Mustafa R, et al.

    Cureus 2024; (16(10)):e71524 doi:10.7759/cureus.71524.

    PMID: 39544555
  4. 4

    Cause of recurrent rhabdomyolysis, carnitine palmitoyltransferase II deficiency and novel pathogenic mutation.

    Çakar NE, Gör Z, Yeşil G

    Ideggyogyaszati szemle 2021; (74(3-4)):135-138 doi:10.18071/isz.74.0135.

    PMID: 33938664
  5. 5

    Recurrent Myalgia since Early Infancy-Misleading Clinical Course in a Child with Carnitine Palmitoyltransferase-II Deficiency.

    Arélin M, Zierz S, Ceglarek U, et al.

    Neuropediatrics 2020; (51(1)):53-56 doi:10.1055/s-0039-1694977.

    PMID: 31541997
  6. 6

    A surviving 24-month-old patient with neonatal-onset carnitine palmitoyltransferase II deficiency.

    Ikeda N, Maruyama S, Nakano K, et al.

    Molecular genetics and metabolism reports 2017; (11()):69-71 doi:10.1016/j.ymgmr.2017.04.010.

    PMID: 28529889
  7. 7

    Inborn Errors of Metabolism with Myopathy: Defects of Fatty Acid Oxidation and the Carnitine Shuttle System.

    El-Gharbawy A, Vockley J

    Pediatric clinics of North America 2018; (65(2)):317-335 doi:10.1016/j.pcl.2017.11.006.

    PMID: 29502916
  8. 8

    Therapeutic potential of triheptanoin in metabolic and neurodegenerative diseases.

    Wehbe Z, Tucci S

    Journal of inherited metabolic disease 2020; (43(3)):385-391 doi:10.1002/jimd.12199.

    PMID: 31778232
  9. 9

    Medium branched chain fatty acids improve the profile of tricarboxylic acid cycle intermediates in mitochondrial fatty acid β-oxidation deficient cells: A comparative study.

    Karunanidhi A, Van't Land C, Rajasundaram D, et al.

    Journal of inherited metabolic disease 2022; (45(3)):541-556 doi:10.1002/jimd.12480.

    PMID: 35076099
  10. 10

    Dietary management and major clinical events in patients with long-chain fatty acid oxidation disorders enrolled in a phase 2 triheptanoin study.

    Vockley J, Longo N, Madden M, et al.

    Clinical nutrition ESPEN 2021; (41()):293-298 doi:10.1016/j.clnesp.2020.11.018.

    PMID: 33487279
  11. 11

    Triheptanoin in patients with long-chain fatty acid oxidation disorders: clinical experience in Italy.

    Porta F, Maiorana A, Gragnaniello V, et al.

    Italian journal of pediatrics 2024; (50(1)):204 doi:10.1186/s13052-024-01782-y.

    PMID: 39375714
  12. 12

    Carnitine palmitoyltransferase II deficiency and post-COVID vaccination rhabdomyolysis.

    Tan A, Stepien KM, Narayana STK

    QJM : monthly journal of the Association of Physicians 2021; (114(8)):596-597 doi:10.1093/qjmed/hcab077.

    PMID: 33871650
  13. 13

    Carnitine Palmitoyltransferase II Deficiency (CPT II) Followed By Rhabdomyolysis and Acute Kidney Injury.

    Gjorgjievski N, Dzekova-Vidimliski P, Petronijevic Z, et al.

    Open access Macedonian journal of medical sciences 2018; (6(4)):666-668 doi:10.3889/oamjms.2018.158.

    PMID: 29731937
  14. 14

    Adult-onset carnitine palmitoyl transferase II (CPT II) deficiency presenting with rhabdomyolysis and acute kidney injury.

    Akar HT, Yıldız Y, Mutluay R, et al.

    CEN case reports 2024; (13(2)):81-85 doi:10.1007/s13730-023-00804-8.

    PMID: 37341884
  15. 15

    Recurrent rhabdomyolysis caused by carnitine palmitoyltransferase II deficiency, common but under-recognised: Lessons to be learnt.

    Balasubramanian M, Jenkins TM, Kirk RJ, et al.

    Molecular genetics and metabolism reports 2018; (15()):69-70 doi:10.1016/j.ymgmr.2018.02.008.

    PMID: 29744303
  16. 16

    A rare cause of acute kidney injury due to recurrent rhabdomyolysis: Carnitine palmitoyltransferase 2 deficiency.

    Ozkan Kurtgoz P, Karakose S, Guney I

    Hemodialysis international. International Symposium on Home Hemodialysis 2025; (29(1)):130-133 doi:10.1111/hdi.13195.

    PMID: 39670416

This page explains standard treatment and management strategies for CPT II deficiency for educational purposes. Always consult your metabolic specialist before adjusting your diet, fasting limits, or exercise routine.

Get notified when new evidence is published on Carnitine palmitoyltransferase II deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.